These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 29604434

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The difference between 2-hour post-challenge and fasting plasma glucose associates with the risk of cardiovascular disease in a normoglycemic population: the Tehran lipid and glucose study.
    Abdi A, Kohansal K, Khalili D, Azizi F, Hadaegh F.
    Nutr Metab (Lond); 2024 Feb 22; 21(1):10. PubMed ID: 38389086
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
    Brodin E, Lerstad G, Grimnes G, Brækkan SK, Vik A, Brox J, Svartberg J, Jorde R, Hansen JB.
    Thromb Haemost; 2013 May 22; 109(5):885-90. PubMed ID: 23446951
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study.
    Zöller B, Pirouzifard M, Sundquist J, Sundquist K.
    J Thromb Thrombolysis; 2017 May 22; 43(4):469-475. PubMed ID: 27990607
    [Abstract] [Full Text] [Related]

  • 29. Microalbuminuria and risk of venous thromboembolism.
    Mahmoodi BK, Gansevoort RT, Veeger NJ, Matthews AG, Navis G, Hillege HL, van der Meer J, Prevention of Renal and Vascular End-stage Disease (PREVEND) Study Group.
    JAMA; 2009 May 06; 301(17):1790-7. PubMed ID: 19417196
    [Abstract] [Full Text] [Related]

  • 30. Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence.
    Kunutsor SK, Seidu S, Blom AW, Khunti K, Laukkanen JA.
    Eur J Epidemiol; 2017 Aug 06; 32(8):657-667. PubMed ID: 28718029
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Time to Event Analysis for the Development of Venous Thromboembolism After Spinal Fusion ≥ 5 Levels.
    McClendon J, Smith TR, O'Shaughnessy BA, Sugrue PA, Thompson SE, Koski TR.
    World Neurosurg; 2015 Sep 06; 84(3):826-33. PubMed ID: 25871780
    [Abstract] [Full Text] [Related]

  • 33. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, Mayer A, Haas T, Kaser A, Feichtenschlager T, Fuchssteiner H, Knoflach P, Vogelsang H, Miehsler W, Platzer R, Tillinger W, Jaritz B, Schmid A, Blaha B, Dejaco C, Eichinger S.
    Gastroenterology; 2010 Sep 06; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hyperglycemia, assessed according to HbA1c , and future risk of venous thromboembolism: the Tromsø study.
    Lerstad G, Brodin EE, Enga KF, Jorde R, Schirmer H, Njølstad I, Svartberg J, Braekkan SK, Hansen JB.
    J Thromb Haemost; 2014 Sep 06; 12(3):313-9. PubMed ID: 24382156
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.